Medical News

RSS

Data demonstrating effectiveness of KALBITOR to treat acute HAE presented at AAAAI 2010 Annual Meeting

Data demonstrating the effectiveness of KALBITOR (ecallantide) to treat hereditary angioedema (HAE) acute attacks by primary attack location were provided in an oral presentation yesterday at the American Academy of Allergy, Asthma and Immunology 2010 Annual Meeting in New Orleans.

3 Mar 2010

FDA approves Mylan Pharmaceuticals' ANDA for Ursodiol Capsules

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Ursodiol Capsules USP, 300 mg, the generic version of Watson's gastrointestinal agent Actigall® Capsules.

3 Mar 2010

Study shows income is not a primary factor in medication adherence

Only 68 percent of corporate executives took their cholesterol lowering medication as prescribed by a doctor, a new study shows.

3 Mar 2010

Public education campaign launched to promote benefits of hearing aids

The American Academy of Audiology on behalf of audiologists, and the Hearing Loss Association of America on behalf of people with hearing loss announce a collaborative public education campaign "Get in the Hearing Loop."

3 Mar 2010

Novo Nordisk awarded contract by VA as primary source provider of insulin

Novo Nordisk, a global healthcare company and leader in diabetes care, announced it has been awarded a contract by the U.S. Department of Veterans Affairs as the primary source provider of insulin. The one year contract began on March 1, 2010 and the VA has the option to renew the contract annually for up to an additional four years.

From Novo Nordisk 3 Mar 2010

Parity law expands mental health access

This Kaiser Health News story, written by Sandra Boodman and produced in collaboration with The Washington Post, reports on the impact of a law that went into effect Jan. 1.

3 Mar 2010

Benefits of aspirin therapy for patients with peripheral artery disease remain unproven

Individuals who were identified as being at increased risk of cardiovascular or cerebrovascular events based on screening for low ankle brachial index, a type of pressure measurement used in the diagnosis of peripheral artery disease, did not significantly reduce their risk of these events with the use of aspirin, according to a study in the March 3 issue of JAMA.

3 Mar 2010

Investigators use ANNs to recognize risk factors of AD in patients with MCI

Mild cognitive impairment (MCI) is often considered an early symptom of Alzheimer's disease (AD). An analysis of genetic risk factors predisposing to MCI is critical for accessing individual predisposition and reliably evaluating the effectiveness of early treatment. In a groundbreaking study published in the February 2010 issue of the Journal of Alzheimer's Disease investigators successfully used artificial neural networks (ANNs) to help understand the causal relation between multiple factors and the occurrence of neurodegenerative disorders.

3 Mar 2010

MRG: Preliminary results from CREST will increase growth in carotid stenting procedures

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, recent preliminary results from the CREST (Carotid Revascularization Endarterectomy versus Stenting Trial) will support growth in carotid stenting procedures of more than 10% over the next five years. The results were announced last week at the American Stroke Association International Stroke Conference 2010.

3 Mar 2010

Biomagnetics Diagnostics announces accelerated delivery timetable for integrated optical biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced its accelerated timetable for delivery of the world's first handheld, integrated optical biosensor.

3 Mar 2010

Solasia Pharma K.K. signs License and Supply Agreement with Kyowa Hakko Kirin to market SP-01

Solasia Pharma K.K. (http://www.solasia.co.jp), a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today the signing of a License and Supply Agreement with Kyowa Hakko Kirin that provides Kyowa Hakko Kirin with an exclusive right to market and sell SP-01 (extended release transdermal granisetron patch; brand name: Sancuso®) in Taiwan, Hong Kong, Singapore and Malaysia.

3 Mar 2010

IntelliDose introduces new, integrated clinical software for medical oncology practices

IntelliDose®, a leading clinical software to manage medical oncology practices, today introduces IntelliScribe™ – a new, fully integrated module in the IntelliDose workflow – to electronically generate prescriptions at any point in the chemotherapy order writing process.

3 Mar 2010

NPS Pharmaceuticals sells royalty rights from sales of REGPARA to DRI Capital's fund

NPS Pharmaceuticals, Inc. today announced the sale of its royalty rights from sales of REGPARA® (cinacalcet HCl) to a fund managed by DRI Capital, Inc., (Fund) for $38.4 million. Royalties in excess of cumulative royalties of $96 million or 2.5 times the upfront purchase price have been retained by NPS.

3 Mar 2010

Pycnogenol counteracts kidney damage caused by hypertension, improves blood flow to the kidneys

An estimated one in ten adults suffers from kidney disease, according to the National Institute of Diabetes and Digestive and Kidney Diseases. A leading cause of kidney disease is hypertension, which effects one out of every four U.S. adults. Chronically high blood pressure damages capillaries of the kidneys which in turn affects the organ's ability to filter waste and remove excess fluids from the body.

3 Mar 2010

Obama says he's willing to explore ideas raised by GOP during health summit

ABC News Political Punch: In a letter to Congressional leaders President Obama signaled Tuesday afternoon he is "open to several provisions raised by GOP lawmakers during last week's bipartisan health care reform summit, including medical malpractice reform, combating fraud," and the removal of a provisions that would have allowed the federal government to pay for Nebraska's Medicaid expansion and another that would have protected Florida seniors from cuts to the Medicare Advantage program (3/2).

3 Mar 2010

Pioneering stem cell research could revolutionize treatments for diabetes and Alzheimer's disease

A heart patient's own skin cells soon could be used to repair damaged cardiac tissue thanks to pioneering stem cell research of the University of Houston's newest biomedical scientist, Robert Schwartz.

3 Mar 2010

TomTec Imaging Systems to present radiology and software solutions at the upcoming ECR

Customers and business partners are invited to visit TomTec’s booth at the upcoming ECR in Vienna.

3 Mar 2010

Enlarged prostate: Dutasteride-tamsulosin combination therapy more effective

Like any successful team effort, the best qualities of two drugs commonly prescribed for enlarged prostate yielded better results than either of the medicines alone, according to a new study from UT Southwestern Medical Center.

3 Mar 2010

Findings could lead to new cancer-fighting drugs

A new study is providing insight into how estrogen fuels many breast cancers, and researchers say the findings could lead to new cancer-fighting drugs.

3 Mar 2010

U.N. meeting examines progress, challenges in achieving women's empowerment

Despite gains in women's rights in the 15 years since the Beijing Declaration, U.N. Female Deputy Secretary-General Asha-Rose Migiro on Monday during the opening of the U.N. Commission on the Status of Women (CSW) meeting acknowledged more action is needed to help countries advance gender equality and women's empowerment, VOA News reports.

3 Mar 2010

Medical News

Data demonstrating effectiveness of KALBITOR to treat acute HAE presented at AAAAI 2010 Annual Meeting

FDA approves Mylan Pharmaceuticals' ANDA for Ursodiol Capsules

Study shows income is not a primary factor in medication adherence

Public education campaign launched to promote benefits of hearing aids

Novo Nordisk awarded contract by VA as primary source provider of insulin

Parity law expands mental health access

Benefits of aspirin therapy for patients with peripheral artery disease remain unproven

Investigators use ANNs to recognize risk factors of AD in patients with MCI

MRG: Preliminary results from CREST will increase growth in carotid stenting procedures

Biomagnetics Diagnostics announces accelerated delivery timetable for integrated optical biosensor

Solasia Pharma K.K. signs License and Supply Agreement with Kyowa Hakko Kirin to market SP-01

IntelliDose introduces new, integrated clinical software for medical oncology practices

NPS Pharmaceuticals sells royalty rights from sales of REGPARA to DRI Capital's fund

Pycnogenol counteracts kidney damage caused by hypertension, improves blood flow to the kidneys

Obama says he's willing to explore ideas raised by GOP during health summit

Pioneering stem cell research could revolutionize treatments for diabetes and Alzheimer's disease

TomTec Imaging Systems to present radiology and software solutions at the upcoming ECR

Enlarged prostate: Dutasteride-tamsulosin combination therapy more effective

Findings could lead to new cancer-fighting drugs

U.N. meeting examines progress, challenges in achieving women's empowerment

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News